PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata; Keng‐Hsueh Lan; Xiaoyan Zhou; Ming Tan; Francisco J. Esteva; Ayşegül A. Şahin; Kristine S. Klos; Ping Li; Brett P. Monia; Nina Nguyen; Gabriel N. Hortobágyi; Mien‐Chie Hung; Dihua Yu

doi:10.1016/j.ccr.2004.06.022

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients

Yoichi Nagata(The University of Texas MD Anderson Cancer Center), Keng‐Hsueh Lan(The University of Texas MD Anderson Cancer Center), Xiaoyan Zhou(The University of Texas MD Anderson Cancer Center), Ming Tan(The University of Texas MD Anderson Cancer Center), Francisco J. Esteva(The University of Texas MD Anderson Cancer Center), Ayşegül A. Şahin(The University of Texas MD Anderson Cancer Center), Kristine S. Klos(The University of Texas MD Anderson Cancer Center), Ping Li(The University of Texas MD Anderson Cancer Center), Brett P. Monia(Ionis Pharmaceuticals (United States)), Nina Nguyen(The University of Texas MD Anderson Cancer Center), Gabriel N. Hortobágyi(The University of Texas MD Anderson Cancer Center), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center), Dihua Yu(The University of Texas MD Anderson Cancer Center)

Cancer Cell

August 1, 2004

10.1016/j.ccr.2004.06.022

Cited by 1,865Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis